Campbell & Co Investment Adviser’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,780
Closed -$180K 1310
2025
Q2
$180K Sell
19,780
-107,846
-85% -$795K 0.01% 1067
2025
Q1
$1.15M Buy
+127,626
New +$1.35M 0.09% 371
2024
Q3
Sell
-67,250
Closed -$908K 1259
2024
Q2
$908K Buy
+67,250
New +$1.38M 0.08% 402
2024
Q1
Sell
-44,211
Closed -$852K 1301
2023
Q4
$852K Buy
+44,211
New +$801K 0.08% 460
2023
Q3
Sell
-30,283
Closed -$577K 1118
2023
Q2
$577K Sell
30,283
-4,335
-13% -$77.3K 0.1% 353
2023
Q1
$504K Buy
34,618
+24,127
+230% +$432K 0.09% 419
2022
Q4
$205K Sell
10,491
-41,850
-80% -$816K 0.05% 687
2022
Q3
$1.26M Buy
52,341
+15,737
+43% +$485K 0.29% 76
2022
Q2
$1.15M Buy
+36,604
New +$1.33M 0.31% 55
2022
Q1
Sell
-9,589
Closed -$417K 847
2021
Q4
$417K Buy
+9,589
New +$376K 0.14% 248
2019
Q2
Sell
-49,840
Closed -$204K 654
2019
Q1
$204K Buy
49,840
+37,740
+312% +$239K 0.1% 447
2018
Q4
$85K Buy
+12,100
New +$126K 0.08% 310
2018
Q3
Sell
-17,777
Closed -$297K 483
2018
Q2
$297K Buy
+17,777
New +$288K 0.23% 198

Other funds holding ACH

Campbell & Co Investment Adviser's ACH Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 19,780 shares — an estimated $180K sold.

Campbell & Co Investment Adviser first reported a position in ACH in Q2 2018 and held it in 13 quarters. The position peaked at $1.26M in Q3 2022. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Campbell & Co Investment Adviser reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 19,780 Accendra Health shares in Q3 2025, an estimated $180K.
  • Campbell & Co Investment Adviser first reported a position in Accendra Health in Q2 2018 and held it in 13 quarters.
  • Campbell & Co Investment Adviser's Accendra Health position peaked at $1.26M in Q3 2022.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.